DRUG · Unmapped registry intervention
HS-10380
Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
NCT07759869
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
SCHIZOPHRENIA 1 (Disorder)unresolved
Interventions
HS-10380DRUG
Sponsors & collaborators
Jiangsu Hansoh Pharmaceutical Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07759869 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.